Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer

Area of Science:

• Cell Biology
• Biochemistry
• Oncology

Background:

• Mitochondria are vital for cellular energy, apoptosis, calcium regulation, and metabolism.
• Cancer progression and chemoresistance are linked to genetic mutations and altered cell signaling.
• Drug-resistant cancer cells often display deregulated mitochondrial function, increased mitochondrial biogenesis, and altered dynamics.

Purpose of the Study:

• To review the critical role of mitochondrial dysfunction in cancer chemoresistance.
• To explore the mechanisms linking mitochondrial dysfunction to chemoresistance, including apoptosis, autophagy/mitophagy, and cancer stemness.
• To highlight the potential of mitochondria-targeted therapies for overcoming chemoresistance.

Main Methods:

• Literature review of scientific articles on mitochondria, cancer, and chemoresistance.
• Analysis of studies investigating the link between mitochondrial function and drug resistance in various cancer types.
• Synthesis of information on the role of cancer stem cells and mitochondrial dysfunction in treatment failure.

Main Results:

• Mitochondrial dysfunction, including increased biogenesis and altered dynamics, contributes significantly to chemoresistance.
• Cancer stem cells, a subpopulation within tumors, exhibit mitochondrial dysfunction and are key drivers of chemoresistance.
• Processes like apoptosis and autophagy/mitophagy are modulated by mitochondrial dysfunction, influencing treatment outcomes.

Conclusions:

• Mitochondrial dysfunction is a central mechanism underlying cancer chemoresistance.
• Targeting mitochondrial pathways presents a promising therapeutic avenue to combat drug-resistant cancers.
• Further research into mitochondria-targeted strategies could improve cancer treatment efficacy and patient survival.